Image |
|
Product Name |
|
Characteristic |
|
5% glucose injection |
|
Capacity : 50,100,200,500,1000㎖ |
|
Effects : Moisture supply for dehydration, Especially moisture |
|
deficiency, Injection dissolution diluent |
|
|
0.9% physiological salt injection |
|
Capacity : 50,100,500,1000㎖ |
|
Effects : Supply for water deficiency, and electrolyte deficiency |
|
(Natrium deficiency, Chlorine deficiency), |
|
Injection dissolution diluent |
|
|
Hartmann Dex |
|
Capacity : 500,1000㎖ |
|
Effects : Supply and correction of extracellular fluid in the case of |
|
decreasing circulating blood volume and tissue interstitial |
|
fluid, Metabolic acidosis correction, Supply energy |
|
|
Physiological salt perfusate |
|
Capacity : 3000㎖ |
|
Effects : Perfusion and detergents |
|
|
Sodium chloride/glucose injection 1:4 |
|
Capacity : 500,1000㎖ |
|
Effects : Supply of water and electrolyte before and after dehydration |
|
and energy |
|
|
Sodium chloride/glucose injection 1:3 |
|
Capacity : 500㎖ |
|
Effects : Supply of water and electrolyte before and after dehydration |
|
and energy |
|
|
Sodium chloride/glucose injection 1:2 |
|
Capacity : 500㎖ |
|
Effects : Supply of water and electrolyte before and after dehydration |
|
and energy |
|
|
10% glucose injection |
|
Capacity : 500,1000㎖ |
|
Effects : Supply energy in the case of hyperpotassemia, Circulatory |
|
collapse, and hypoglycemia, Heart disease (G, I, K therapy) |
|
the rest of moisture, Energy supply, Drug/poison addiction |
|
|
5% glucose natrium kalium injection 3 |
|
Capacity : 500㎖ |
|
Effects : Supply of water and electrolyte before and after dehydration |
|
and energy |
|
|
5% glucose natrium kalium injection 2 |
|
Capacity : 1000㎖ |
|
Effects : Supply of water and electrolyte before and after dehydration |
|
and energy |
|
|
0.45% physiological salt injection |
|
Capacity : 1000㎖ |
|
Effects : |
*0.45, 0.9% injection : Supply when in water and electrolyte
deficiency (natrium deficiency, Chlorine deficiency), Injection
dissolution diluent |
*Kit injection : Injection dissolution diluent |
*3% injection : Quick supply of water and electrolyte, used
especially in the following cases : |
- Hyponatraemia or hypochloremia
- In the case of intense dilution of extracellular liquid following the
perfusate perfusion to the open sinus venosus during large intake
of water due to repeated enema or transurethral prostatectomy.
- First aid for severe saline depletion |
*11.7% injection : Electrolyte correction of electrolyte replacement
fluid (Hyponatraemia, Hypochloremia) |
|
|
5% fructose injection |
|
Capacity : 500㎖ |
|
Effects : Energy supply for diabetes or the state of diabetes, |
|
Drug addiction, Alcohol addiction, For other cases where |
|
parenterally water and energy supply is needed parenterally |
|
where water and energy supply is needed parenterally, |
|
Injection dissolution diluent |
|
|
10% glycerin 5% fructose injection |
|
Capacity : 500㎖ |
|
Effects : Intracranial hypertension, Cranial edema, Intracranial |
|
hypertension, Improvement of clouded consciousness, |
|
Neuropathy, and subjective symptom by cranial edema |
|
improvement, Post brain surgery therapy, |
|
Reduction of brain capacity during brain surgery |
|
When intraocular pressure needs to be lowered |
|
Eye capacity reduction during ophthalmological operation |
|
|
Injection water |
|
Capacity : 1000㎖ |
|
Effects : Used for dispensing eye bath drops, injection reagent etc. |
|
and medicine production |
|
|
Plasma solution A |
|
Capacity : 1000㎖ |
|
Effects : Supply and correction of extracellular fluid in the case of |
|
decreasing circulating blood volume and tissue interstitial |
|
fluid, metabolic acidosis correction |
|
|
Hartmann solution |
|
Capacity : 500,1000㎖ |
|
Effects : Supply and correction of extracellular fluid in the case of |
|
decreasing circulating blood volume and tissue interstitial |
|
fluid, metabolic acidosis correction |
|
|
5% glucose physiological salt injection |
|
Capacity : 500,1000㎖ |
|
Effects : Supply of water and electrolyte before and after |
|
dehydration, Operation, Energy supply |
|
|
Hydrochloric acid dopamine premix injection |
|
Capacity : 160㎎/500㎖, 1320㎎/250㎖, 80㎎/500㎖ |
|
Effects : Myocardial infarction, External injury, Internal toxity, |
|
Blood poisoning, Caused by post-operation renal |
|
disorder/chronic cardiac decompensation (congestive |
|
heart failure), Uropenia, Anuresis, Low blood pressure |
|
due to decrease cardiac output |
|
|
Dobutamine premix injection |
|
Capacity : 100㎎/500㎖, 200㎎/250㎖, 400㎎/500㎖ |
|
Effects : Increase of heart beat when giving short-term treatment |
|
cardiac insufficiency caused by heart disease or heart operation |
|
|
8.5% Fravasol injection |
|
Capacity : 250,500㎖ |
|
Effects : Supply of amino acid for the following cases : |
|
Hypoproteinemia, Subnutrition state, Before and after operation |
|
|
10% Fravasol |
|
Capacity : 250, 500㎖ |
|
Effects : Supply of amino acid for the following cases : |
|
Hypoproteinemia, Hypoproteinemia, Subnutrition state, |
|
Before and after operation |
|
|
Livaframin |
|
Capacity : 250, 500㎖ |
|
Effects : Improving encephalosis caused by acute/chronic liver |
|
failure, supplying amino acid for hepatopath |
|
|
Citopcin |
|
Capacity : 100㎎/50㎖, 200㎎/100㎖, 400㎎/200㎖ |
|
|